record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundexperimental · manual state transition; control details require source inspection · Homo sapiens
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition; control details require source inspection
evidence type
experimental
species
Homo sapiens
evidence spans
Lecanemab Treatment in a Specialty Memory Clinic. — ImportanceTwo monoclonal antibodies targeting amyloid plaques, lecanemab and donanemab, have received traditional US Food and Drug Administration (FDA) approval for the treatment of early symptomatic Alzheimer disease (AD). The most significant adverse events...
Paczynski M; Hofmann A; Posey Z; Gregersen M; Rudman M; Ellington D. JAMA neurology 2025. doi:10.1001/jamaneurol.2025.1232 · curator_source · 10.1001/jamaneurol.2025.1232
conditions
Provenance
source title
Paczynski M; Hofmann A; Posey Z; Gregersen M; Rudman M; Ellington D. JAMA neurology 2025. doi:10.1001/jamaneurol.2025.1232
doi
10.1001/jamaneurol.2025.1232
journal
JAMA neurology
authors
Paczynski M, Hofmann A, Posey Z, Gregersen M, Rudman M, Ellington D
Lecanemab Treatment in a Specialty Memory Clinic. — ImportanceTwo monoclonal antibodies targeting amyloid plaques, lecanemab and donanemab, have received traditional US Food and Drug Administration (FDA) approval for the treatment of early symptomatic Alzheimer disease (AD). The most significant adverse events...
vs_44bef0b10142602a · source:Paczynski M; Hofmann A; Posey Z; Gregersen M; Rudman M; Ellington D. JAMA neurology 2025. doi:10.1001/jamaneurol.2025.1232|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_bb6b46607ed702e7finding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_5fdd386b6da77f47finding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.